These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17012119)

  • 21. Influence of the surface tension of wet massing liquid on the functionality of microcrystalline cellulose as pelletization aid.
    Elsergany RN; Lenhart V; Kleinebudde P
    Eur J Pharm Biopharm; 2020 Aug; 153():285-296. PubMed ID: 32599270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
    Thommes M; Kleinebudde P
    AAPS PharmSciTech; 2007 Nov; 8(4):E95. PubMed ID: 18181555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of drug loading capacity of cellactose with two ad hoc processed lactose-cellulose direct compression excipients.
    Casalderrey M; Souto C; Concheiro A; Gómez-Amoza JL; Martínez-Pacheco R
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):398-401. PubMed ID: 15056951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug.
    Alvarez L; Concheiro A; Gómez-Amoza JL; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2003 May; 55(3):291-5. PubMed ID: 12754003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex dielectric properties of microcrystalline cellulose, anhydrous lactose, and α-lactose monohydrate powders using a microwave-based open-reflection resonator sensor.
    Sung PF; Hsieh YL; Angonese K; Dunn D; King RJ; Machbitz R; Christianson A; Chappell WJ; Taylor LS; Harris MT
    J Pharm Sci; 2011 Jul; 100(7):2920-34. PubMed ID: 21328582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials.
    Faqih AM; Mehrotra A; Hammond SV; Muzzio FJ
    Int J Pharm; 2007 May; 336(2):338-45. PubMed ID: 17289312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Eur J Pharm Biopharm; 2011 Nov; 79(3):658-63. PubMed ID: 21827853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental studies on the effect of moisture content and volume resistivity on electrostatic behaviour of pharmaceutical powders.
    Choi K; Taghavivand M; Zhang L
    Int J Pharm; 2017 Mar; 519(1-2):98-103. PubMed ID: 28062366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
    Gómez-Carracedo A; Souto C; Marti Nez-Pacheco R; Concheiro A; Gómez-Amoza JL
    Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved tabletability after a polymorphic transition of delta-mannitol during twin screw granulation.
    Vanhoorne V; Bekaert B; Peeters E; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2016 Jun; 506(1-2):13-24. PubMed ID: 27094358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-emulsifying pellets: relations between kinetic parameters of drug release and emulsion reconstitution-influence of formulation variables.
    Nikolakakis I; Malamataris S
    J Pharm Sci; 2014 May; 103(5):1453-65. PubMed ID: 24596121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
    AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physico-Mechanical Properties of Coprocessed Excipient MicroceLac® 100 by DM(3) Approach.
    Haware RV; Kancharla JP; Udupa AK; Staton S; Gupta MR; Al-Achi A; Stagner WC
    Pharm Res; 2015 Nov; 32(11):3618-35. PubMed ID: 26055403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2010 Dec; 15(6):626-35. PubMed ID: 20148708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality by Design (QbD) Approach for Development of Co-Processed Excipient Pellets (MOMLETS) By Extrusion-Spheronization Technique.
    Patel H; Patel K; Tiwari S; Pandey S; Shah S; Gohel M
    Recent Pat Drug Deliv Formul; 2016; 10(3):192-206. PubMed ID: 27396400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manufacture of fine spherical granules by an extrusion/spheronization method.
    Kanbe H; Hayashi T; Onuki Y; Sonobe T
    Int J Pharm; 2007 Jun; 337(1-2):56-62. PubMed ID: 17257789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation and functionality of inhalation anhydrous lactose.
    Pitchayajittipong C; Price R; Shur J; Kaerger JS; Edge S
    Int J Pharm; 2010 May; 390(2):134-41. PubMed ID: 20100552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.